Miller School Spinoff Uses RNA to Tackle Deadly Disease
December 14, 2024
December 14, 2024
MIAMI, Florida, Dec. 14 (TNSres) -- The University of Miami Miller School of Medicine issued the following news:
* * *
Article Summary
* WiNK Therapeutics was honored at the Florida Innovation Conference as the most promising, emerging company.
* Co-founder Dr. Paolo Serafini and team developed RNA aptamers to deliver therapeutics to beta cells in people with diabetes.
* Success will will be a two-part process: replacing the beta c . . .
* * *
Article Summary
* WiNK Therapeutics was honored at the Florida Innovation Conference as the most promising, emerging company.
* Co-founder Dr. Paolo Serafini and team developed RNA aptamers to deliver therapeutics to beta cells in people with diabetes.
* Success will will be a two-part process: replacing the beta c . . .